title: Effects of intravenous cyclophosphamide in severe proliferative lupus glomerulonephritis.
authors.affiliation: Division of Nephrology, Hospital General Valle de Hebrón, Barcelona, Spain.
authors.forename: J L
authors.initials: JL
authors.lastname: Tovar
authors.forename: J
authors.initials: J
authors.lastname: Ordi
authors.forename: S
authors.initials: S
authors.lastname: Martinez
authors.forename: A
authors.initials: A
authors.lastname: Raventos
authors.forename: M
authors.initials: M
authors.lastname: Ramirez de Arellano
authors.forename: A
authors.initials: A
authors.lastname: Selva
authors.forename: M T
authors.initials: MT
authors.lastname: Vidal
authors.forename: L
authors.initials: L
authors.lastname: Piera
mesh_terms: D000293:Adolescent; D000328:Adult; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007970:Leukopenia / Q000139:chemically induced; D008181:Lupus Nephritis / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D008297:Male
chemical_list: D003520:Cyclophosphamide; D003404:Creatinine